| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 3.310.789.984 $ | +1.048.998.718 $ | +49,7 % | 10 | 2.939.552.367 $ | +908.091.996 $ | +64,2 % | 11 | 1.568.047.916 $ | +410.449.518 $ | +40,8 % | 4 | ||||
| Arcellx, Inc. | ACLX | → 0 | 662.972.517 $ | +289.766.674 $ | +77,6 % | 1 | 373.205.843 $ | -8.478.371 $ | -2,2 % | 1 | 381.684.214 $ | +75.546.510 $ | +24,7 % | 1 | |
| Revolution Medicines, Inc. | RVMD | → 0 | Neutral | 647.267.117 $ | +118.040.418 $ | +22,3 % | 1 | 529.226.699 $ | +238.599.009 $ | +82,1 % | 1 | 290.627.690 $ | +66.455.514 $ | +29,6 % | 1 |
| Nuvalent, Inc. | NUVL | → 0 | 545.488.161 $ | +15.435.896 $ | +2,9 % | 1 | 530.052.265 $ | +74.351.699 $ | +16,3 % | 1 | 455.700.566 $ | +53.642.828 $ | +13,3 % | 1 | |
| Merus N.V. | → 0 | 440.035.446 $ | +214.804.666 $ | +95,4 % | 1 | ||||||||||
| Vaxcyte, Inc. | PCVX | → 0 | Neutral | 278.522.392 $ | +90.823.949 $ | +48,4 % | 1 | 187.698.443 $ | +51.371.568 $ | +37,7 % | 1 | ||||
| Edgewise Therapeutics, Inc. | EWTX | → 0 | Schwach | 231.998.697 $ | +69.678.571 $ | +42,9 % | 1 | 162.320.126 $ | +62.240.601 $ | +62,2 % | 1 | ||||
| GENMAB A/S | GMAB | → 0 | Sehr stark | 213.777.040 $ | -3.049.847 $ | -1,4 % | 1 | 216.826.887 $ | +99.764.067 $ | +85,2 % | 1 | ||||
| Tarsus Pharmaceuticals, Inc. | TARS | → 0 | Neutral | 179.735.103 $ | -30.054.067 $ | -14,3 % | 1 | 209.789.170 $ | +51.366.738 $ | +32,4 % | 1 | ||||
| INSMED Inc | INSM | → 0 | Schwach | 205.133.878 $ | +205.133.878 $ | 1 | |||||||||
| Abivax S.A. | ABVX | → 0 | Sehr schwach | 191.153.321 $ | +58.353.081 $ | +43,9 % | 1 | ||||||||
| Olema Pharmaceuticals, Inc. | OLMA | → 0 | Stark | 188.604.300 $ | +122.089.356 $ | +183,6 % | 1 | ||||||||
| FINANCIAL COUNSELORS INC | → 0 | 182.895.000 $ | +82.695.000 $ | +82,5 % | 1 | ||||||||||
| BELITE BIO, INC | BLTE | → 0 | 177.741.161 $ | +177.741.161 $ | 1 | ||||||||||
| Erasca, Inc. | ERAS | → 0 | Schwach | 168.153.918 $ | +115.482.085 $ | +219,2 % | 1 | ||||||||
| Cidara Therapeutics, Inc. | → 0 | 167.780.313 $ | +75.739.248 $ | +82,3 % | 1 | ||||||||||
| 3.310.789.984 $ | +1.048.998.718 $ | +49,7 % | 10 | 2.939.552.367 $ | +908.091.996 $ | +64,2 % | 11 | 1.568.047.916 $ | +410.449.518 $ | +40,8 % | 4 | ||||